WAF1 expression and p53 mutations in human colorectal cancers

Journal of Cancer Research and Clinical Oncology

Volumn 123, Issue 2, 1997, Pages 118-123

  Wang, Aijin ^a   Yoshimi, Naoki ^b   Ino, Natsuko ^b   Tanaka, Takuji ^b   Mori, Hideki ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b GIFU UNIVERSITY   (Japan)

Author keywords

colorectal cancer; p53 mutation; PCR SSCP; WAF1; Western blot

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HETEROZYGOTE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEOPLASM METASTASIS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE DELETION;

EID: 0031046787     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01269890     Document Type: Article

References (31)

1. Baker SJ, Markowitz S, Fearon EC, Willson JKV, Vogelstein B (1990a) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915
2. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Willson JKV, Hamilton S, Vogelstein B (1990b) p53 gene mutations occur in combination with 17p allelic deletion as late events in colorectal tumorigenesis. Cancer Res 50:7717-7722
3. Blin N, Safford DM (1976) A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 3:2303-2308
4. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF-1, a potential mediator of P53 tumour suppression. Cell 75:817-825
5. Eliyahu D, Raz A, Gruss P, Givol D, Oren M (1984) Participation of p53 cellular tumour antigen in normal embryonic cells. Science 312:646-649
6. Fenoglio-Preiser MC (1989) Gastro-intestinal pathology, an atlas and text. Raven, New York
7. Gao X, Chen Y, Wu N, Grignon D, Sakr W, Porter A, Honn K (1995) Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer. Oncogene 11:1395-1398
8. Goh H-S, Chan C-S, Khine K, Smith DR (1994) p53 and behaviour of colorectal cancer. Lancet 344:233-234
9. Gyllensten UB, Erlich HA (1988) Generation of single-strand DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci USA 85:7652-7656
10. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 Cdk-interesting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinase. Cell 75:805-816
11. Herskowitz I (1987) Functional inactivation of genes by dominant negative mutations. Nature 329:219-222
12. Hinds P, Finlay C, Levine AJ (1989) Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol 63:739-746
13. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49-53
14. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Vogelstein B (1991) Identification of p53 as a sequence-specific DNA-binding protein. Science 252:1707-1711
15. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinlzer KW, Vogelstein B (1992) Oncogenic form of p53 inhibit p53-regulated gene expression. Science 256:827-830
16. Kosaka C, Saguki T, Masuda J, Zen K, Shimokado K, Yokota T, Ogata J (1993) Protein kinase C-mediated inhibition of cyclin A expression in human vascular endothelial cells. Biochem Biophys Res Commun 193:991-998
17. Lane DP, Crawford LV (1979) T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261-263
18. Li Y, Laurent-Puig P, Salmon R, Thomas G, Hamelin R (1995) Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene 10:599-601
19. Michieli P, Chdid M, Lin D, Pierce JH, Mercer WE, Givol D (1994) Induction of WAF1/CIP1 by p53-independent pathway. Cancer Res 54:3391-3395
20. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FC, Weston A, Modali R, Harris CC, Vogelstein B (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705-708
21. Niwa K, Itoh M, Murase T, Morishita S, Itoh N, Mori H, Tamaya T (1994) Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance. Br J Cancer 70:1191-1197
22. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T (1989a) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766-2770
23. Orita M, Suzuki Y, Sekiya T, Hayashi K (1989b) Rapid and sensitive detection of point mutation and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879
24. Parada LF, Land H, Weinberg RA, Wolf D, Rotter V (1984) Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Science 312:649-651
25. Rodrigues NR, Rowan A, Smith MEF, Kerr I, Bodmer WF, Gannon JV, Lane DP (1990) p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87:7555-7559
26. Sambrook J, Fritsh EF, Maniatis T (1989) Molecular cloning, vol 3. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 18.47-18.75
27. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467
28. Shiohara M, El-Deiry W, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen D, Vogelstein B, Koeffler H (1994) Absence of WAF1 mutations in a variety of human malignancies. Blood 84:3781-3784
29. Suzui M, Yoshimi N, Ushijima T, Hirose Y, Makita H, Wang A, Kawamori T, Tanaka T, Mori H, Nagao M (1995) No involvement of Ki-ras or p53 gene mutations in colitis-associated rat colon tumors induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate. Mol Carcinog 12:193-197
30. Teixeira CR, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G (1994) Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas. Cancer 73:575-579
31. Ullrich SJ, Anderson CW, Mercer WE, Appella E (1992) The p53 tumour suppressor protein, a modulator of cell proliferation. J Biol Chem 267:15259-15262